• 농업과학연구
• /
• 제49권3호
• /
• pp.389-396
• /
• 2022

The purpose of this study was to investigate the safety of Houttuynia cordata Thunb extract (HCE) in Institute of Cancer Research (ICR) mice, to determine the effects of the extract on the growth performance and colony count, and to establish the optimal concentration of HCE. In total, 60 five-week-old male ICR mice with an average initial body weight (BW) of 27.24 ± 0.44 g were used in a four-week experiment. Mice were randomly allotted to four treatment groups (five replications per group, three mice per cage): 1) a control (CON) group fed with normal distilled water; 2) treatment group 1 (T1) fed with normal distilled water containing 0.05% HCE; 3) treatment group 3 (T3) fed with normal distilled water containing 0.1% HCE; and 4) treatment group 3 (T3) fed with normal distilled water containing 0.2% HCE. BW, feed intake (FI), and water intake were measured on the first, fourteenth, and eighteenth days. T2 showed a significant improvement (p < 0.05) in the feed conversion ratio (FCR) over the experimental period. However, water intake levels did not show significant differences among the groups. In the large intestine and feces, E. coli and Lactobacillus levels were significantly improved (p < 0.05) in the HCE treated group compared to the CON group. Supplying HCE via the drinking water improved the growth performance and colony count in ICR mice. Based on results of this study, utilizing HCE in livestock species is expected to be safe and feasible.

• 농업과학연구
• /
• 제48권4호
• /
• pp.1003-1013
• /
• 2021

Thioredoxin (TRX) protein is an antioxidant responsible for reducing other proteins by exchanging cysteine thiol-disulfide and is also known for its anti-allergic and anti-aging properties. On the other hand, epidermal growth factor (EGF) is an important material used in the cosmetics industry and an essential protein necessary for dermal wound healing facilitated by the proliferation and migration of keratinocytes. EGF also assists in the formation of granulation tissues and stimulates the motility of fibroblasts. Hence, genetically modified soybeans were developed to overexpress these industrially important proteins for mass production. A single-dose oral-toxicity-based study was conducted to evaluate the potential toxic effects of TRX and EGF proteins, as safety assessments are necessary for the commercial use of seed-specific protein-expressing transgenic soybeans. To achieve this rationale, TRX and EGF proteins were mass purified from recombinant E. coli. The single-dose oral-toxicity tests of the TRX and EGF proteins were carried out in six-week old male and female Institute of Cancer Research (ICR) mice. The initial evaluation of the single-dose TRF and EGF treatments was based on monitoring the toxicity signatures and mortality rates among the mice, and the resultant mortality rates did not show any specific clinical symptoms related to the proteins. Furthermore, no significant differences were observed in the weights between the treatment and control groups of male and female ICR mice. After 14 days of treatment, no differences were observed in the autopsy reports between the various treatment and control groups. These results suggest that the minimum lethal dose of TRX and EGF proteins is higher than the allowed 2,000 mg·kg^-1 limit.

• Mass Spectrometry Letters
• /
• 제3권4호
• /
• pp.104-107
• /
• 2012

Mollugin isolated from Rubia cordifolia is known to have anti-inflammatory, anti-cancer, and anti-viral activities. In the present study, a cocktail probe assay and LC-MS/MS were used to investigate the modulating effect of mollugin on cytochrome P450 (CYP) enzymes in male ICR mice. After mollugin was orally administrated to mice at the 20, 40, or 80 mg/kg for 3 days, the activities of CYP in hepatic S-9 fractions were investigated. Unlike the selective inhibitory effect of mollugin on CYP1A2-catalyzed phenacetin O-deethylation in vitro, mollugin only significantly inhibited the activity of CYP2E1-catalyzed chlorzoxazone 6-hydroxylase in vivo. The activities of other CYPs were only slightly altered by mollugin. The results of this study suggest that mollugin might cause herb-drug interactions via the selective inhibition of CYP2E1 in vivo.

• 농업과학연구
• /
• 제49권3호
• /
• pp.539-545
• /
• 2022

The aim of this study was to evaluate the effect of beekeeping by-products added to drinking water on the growth performance and intestinal and fecal microflora of Institute of Cancer Research (ICR) mice. A total of 72 five-week-old ICR mice with an initial body weight (BW) of 24.57 ± 0.60 g were used in a two-week experiment. The four treatment groups were as follows; 1) CON, normal distilled water; 2) T1, CON with 0.7% beehive extract; 3) T2, CON with 0.7% propolis (PRO); and 4) T3, CON with 0.7% royal jelly (RJ). Each treatment consisted of 6 replicate cages with 3 mice per cage. At 0 - 1 week, T3 showed a significantly higher (p < 0.05) body weight gain (BWG) and feed efficiency (G : F) than that of CON. Compared with CON, T2 showed a significantly higher (p < 0.05) BWG and feed intake at 1 - 2 weeks. During the entire period, T2 and T3 showed a significantly higher (p < 0.05) BWG and G : F compared to CON. The amount of Salmonella and Lactobacillus in the large intestine was significantly decreased and increased (p < 0.05) in T2 and T3, respectively, compared to CON. The amount of Escherichia coli in the fecal matter was significantly reduced (p < 0.05) compared to CON in all treatment groups to which beekeeping by-products were added. In conclusion, the addition of PRO or RJ to the drinking water of ICR mice had a positive effect on the growth performance and the intestinal and fecal microflora.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권7호
• /
• pp.3343-3347
• /
• 2012

The aim of this study was to investigate the anticlastogenicity as well as the clastogenicity of Eryngium foetidum leaf (EF) using the in vivo mouse peripheral blood erythrocyte micronucleus assay. Eighty ICR male mice were fed AIN-76 diet supplemented with ground freeze-dried EF at 0.0%, 0.8%, 1.6% and 3.2% for 2 weeks prior to the administration of both direct-acting, mitomycin C (MMC), and indirect-acting, 7, 12-dimethylbenz(a) anthracene (DMBA) clastogens. Peripheral blood samples were collected from mice just before administration of clastogen and at 24 and 48 h thereafter for MMC. Blood samples were collected at the same times and after 72 h for DMBA. Then, reticulocytes in blood samples were counted using fluorescent microscopy. The results indicated that EF had no clastogenic effect in mice. All doses of diets supplemented with EF decreased the number of micronucleated peripheral reticulocytes in all the MMC-treated groups in a dose dependent manner, but significant reduction was found only at 1.6% and 3.2% EF in the DMBA-treated groups. It can be concluded that EF has no clastogenicity, but possesses anticlastogenic potential against both direct- and indirect-acting types of clastogen in mice.

• 대한수의학회지
• /
• 제43권3호
• /
• pp.323-331
• /
• 2003

We performed this study to determine the late biological effect of gamma radiation and effect of Bu-Zhong-Yi-Qi-Tang (BZYQT), a prescription of traditional Oriental medicine, on radiation-induced late biological effect (survival, hematological change, carcinogenesis) of mice irradiated with 3 Gy of gamma-radiation. There were little difference in body weights between normal and irradiated mice. Survival rate were decreased in irradiated mice and the survival rate and mean survival time of the groups treated with BZYQT were far better than the irradiation control group. A significant elevation of total leukocyte or lymphocyte counts was seen at week 4 and 12 of the group treated with BZYQT. Stimulated recovery by the extract from BZYQT was also observed in thrombocyte. Main gross findings of irradiated mice were appeared as enlargement of spleen, thymus and liver, tumorous nodules of lung and cyst or mass of ovary. Microscopically, there were various findings including hematopoietic and lymphoid tumor, lung cancer, ovarian cancer and cancer of other lesions. BZYQT reduced the incidence of tumor development. Further studies are needed to characterize better the protective nature of ingredients and active compounds.

• Applied Biological Chemistry
• /
• 제38권4호
• /
• pp.364-369
• /
• 1995

목단피의 mouse 복수암에 대한 항암성을 다른 생약제의 항암성과 비교하여 연구하였다. 천연생약제(목단피, 주목, 울금, 인경쓱, 여정실, 맥문동) methanol 추출물을 hexane, chloroform ($CHCl_3$), ethylacetate (EtOAc), butanol (BuOH)로 fractionation하여 mouse leukemia L1210 cell과 Sarcoma 180 (S-180) cell에 강한 독성을 나타낸 fraction에 대해 mouse 복수암 억제실험을 실시하였다. 복수형 종양세포 S-180을 ICR mouse (male, $6{\sim}7$주령, $23g{\pm}3g$, 처리당 7마리)의 복부에 주사 ($1{\times}10^{6}$ cells/0.1 ml PBS)한 1일 후 부터 10% DMSO에 용해한 시료 ($30{\mu}g/g$ body weight)를 매일 0.1ml씩 10일간 주사하고 수명연장 효과와 몸무게의 변화를 조사하였다. 처리 fraction 중에서 목단피의 EtOAc fraction이 가장 강한 항암성을 보였는데, 수명연장에서는 대조구의 17.2일 (100%)에 비하여 28.7일로서 167%로 연장되었으며, 체중 증가율도 대조구보다 낮았다 (p<0.05). 목단피의 농도별 (5, 10, 30, $60{\mu}g/g$ body weight) 항암효과는 $30{\mu}g$에서 가장 높았고, $60{\mu}g$처리구 에서는 독성이 나타났다. 목단피의 EtOAc fraction으로부터 GC-MS에 의해 잠정적으로 동정된 2-methoxyphenol, 1-(4-hydroxy-3- methoxyphenyl)-ethanone, 8-methyl-2,4(1H,3H)-pteridinedione, 2,5-furandicarboxylic dimethyl ester 가 mouse 복수암 억제에 관련이 있는 주요 화합물로 추정된다.

• 대한암한의학회지
• /
• 제20권2호
• /
• pp.5-11
• /
• 2015

Objective : The objective of this study was to investigate the anti-tumor activity of the complexed herbal formula, Haeamdan (HAD). Methods : Seven Cancer cell lines, LoVo, MCF-7, AGS, Sarcoma 180, HL-60, NCI-H69, LL/2, were prepared and the cytotoxicity was assessed by 3-(4,5-dimethylthiazol-2yl)-2,5-dephenyl tetrazolium bromide (MTT) assay. HAD was applied with various concentrations from 0.1 to 1.0 mg/ml to figure out the appropriate dosage. ICR male mice were intraperitoneally implanted with Sarcoma 180 and divided into 8 species for each group. Control group was treated with normal saline, positive control group was treated with cyclophosphamide 8mg/kg, and experimental group was treated with HAD 1g/kg. Results : Among seven cancer cell lines, HAD exhibited strong cytotoxic activities to followed four cancer cell lines, that is, Sarcoma 180, HL-60, NCI-H69, and LL/2. These cytotoxic activity was expressed under 0.50 mg/ml of IC50 under 0.1~1mg/ml of OBW. When Sarcoma 180 cancer cell was implanted in ICR male mice and treated with the HAD, HAD prolonged the median overall survival for 3.6 days, from 17.5 to 21.1 days. Conclusion : HAD showed strong cytotoxicity to the cancer cells, Sarcoma 180, HL-60, NCI-H69, on in vitro study and it showed anti-tumor activity in vivo with the peritoneal cancer mice by prolonging the median survival for 3.6 days. Further researches would be expected to support the anti-tumor efficacy of HAD.

• Toxicological Research
• /
• 제33권1호
• /
• pp.25-30
• /
• 2017

Saccharin, the first artificial sweetener, was discovered in 1879 that do not have any calories and is approximately 200~700 times sweeter than sugar. Saccharin was the most common domestically produced sweetener in Korea in 2010, and it has been used as an alternative to sugar in many products. The interaction between artificial sweeteners and drugs may affect the drug metabolism in patients with diabetes, cancer, and liver damage, this interaction has not been clarified thus far. Here, we examined the effects of the potential saccharin-drug interaction on the activities of 5 cytochrome P450 (CYPs) in male ICR mice; further, we examined the effects of saccharin (4,000 mg/kg) on the pharmacokinetics of bupropion after pretreatment of mice with saccharin for 7 days and after concomitant administration of bupropion and saccharin. Our results showed saccharin did not have a significant effect on the 5 CYPs in the S9 fractions obtained from the liver of mice. In addition, we observed no differences in the pharmacokinetic parameters of bupropion between the control group and the groups pretreated with saccharin and that receiving concomitant administration of saccharin. Thus, our results showed that saccharin is safe and the risk of saccharin-drug interaction is very low.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
• /
• pp.276.1-276.1
• /
• 2002

It is well known that cisplatin. one of chemotherapeutic agents. induces DNA damage and kill cancer cells mainly by apoptosis. We recently synthesized a novel Pt(IV)-based anticancer agent. trans.cis-Pt(acetato)2C12(1.4-butanediamine) (K101) with octahedral structure. To evaluate antitumor activity about human cancer of K101, we have performed histoculture drug response assay in 35 cases of colorectal cancer patients. (omitted)